Protalix BioTherapeutics
PLX
#8575
Rank
S$0.16 B
Marketcap
$2.23
Share price
-1.78%
Change (1 day)
18.40%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of June 2024 : S$60.57 Million

According to Protalix BioTherapeutics 's latest financial reports the company has S$60.57 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$58.85 M97.92%
2022-12-31S$29.73 M-43.58%
2021-12-31S$52.7 M3.36%
2020-12-31S$50.99 M112.59%
2019-12-31S$23.98 M-53.56%
2018-12-31S$51.65 M-24.52%
2017-12-31S$68.43 M-25.28%
2016-12-31S$91.58 M-15.22%
2015-12-31S$0.10 B49.29%
2014-12-31S$72.36 M-33.89%
2013-12-31S$0.10 B72.02%
2012-12-31S$63.63 M81.98%
2011-12-31S$34.96 M-24.38%
2010-12-31S$46.24 M-59.47%
2009-12-31S$0.11 B87.29%
2008-12-31S$60.91 M-31.52%
2007-12-31S$88.94 M152.7%
2006-12-31S$35.19 M345.91%
2005-12-31S$7.89 M757.92%
2004-12-31S$0.92 M-26%
2003-12-31S$1.24 M-11.27%
2002-12-31S$1.4 M-17.32%
2001-12-31S$1.69 M-39.18%
2000-12-31S$2.78 M13.93%
1999-12-31S$2.44 M14.9%
1998-12-31S$2.12 M130.45%
1997-12-31S$0.92 M-13.59%
1996-12-31S$1.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.33 B 454.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.65 B 2,627.13%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.38 B 22,001.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.46 B 7,270.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel